Continuity Pharma
Continuity Pharma is dedicated to modernizing chemical synthesis processes through innovative chemistry and flow technology. They focus on developing efficient, scalable, and environmentally friendly manufacturing systems for critical medicines, including active pharmaceutical ingredients (APIs). Their mission is to ensure a consistent supply of high-quality medicines, support drug development, and enhance manufacturing resilience, especially in the pharmaceutical, biotech, and agrochemical industries.
Industries
Nr. of Employees
small (1-50)
Continuity Pharma
3000 Kent Ave, Suite 1951, West Lafayette, IN 47906, USA
Products
Lomustine Synthesis in Flow (publication)
Technical publication describing continuous-flow synthesis methods for the active pharmaceutical ingredient lomustine.
Lomustine Synthesis in Flow (publication)
Technical publication describing continuous-flow synthesis methods for the active pharmaceutical ingredient lomustine.
Services
Parallel experimental screening to identify promising synthesis routes, conversions, and impurity profiles.
Verification and optimization of selected conversions to establish process parameters, yields, product composition, and low-waste conditions.
Development and implementation of integrated flow synthesis systems with inline/online analytics for real-time monitoring and control.
Pilot scale identification of quality control points, variability studies, design/build of production systems, and transfer of process knowledge to manufacturing partners.
Parallel experimental screening to identify promising synthesis routes, conversions, and impurity profiles.
Verification and optimization of selected conversions to establish process parameters, yields, product composition, and low-waste conditions.
Development and implementation of integrated flow synthesis systems with inline/online analytics for real-time monitoring and control.
Pilot scale identification of quality control points, variability studies, design/build of production systems, and transfer of process knowledge to manufacturing partners.
Expertise Areas
- Continuous manufacturing for small molecules and APIs
- High-throughput experimentation for reaction and route discovery
- Process development and optimization for chemical synthesis
- Scale-up, pilot studies and technology transfer
Key Technologies
- Continuous flow chemistry
- High-throughput experimentation (HTE)
- Process analytical technology (PAT)
- Integrated multistep flow systems
News & Updates
Partnership to reshore lomustine production in the U.S. using continuous flow technology to improve drug accessibility and affordability for glioblastoma patients.
FDA support for advanced manufacturing technologies, including Continuity Pharma's innovations.
Partnership to reshore lomustine production in the U.S. using continuous flow technology to improve drug accessibility and affordability for glioblastoma patients.
FDA support for advanced manufacturing technologies, including Continuity Pharma's innovations.